Skip to content

Ai

Topic archive • 2 matches

Back to home • GEO summary endpoint

2026-10-21

Investment

  • Orchestra Bio • OpenAI

    OpenAI acquires Orchestra Bio to build drug-development AI agents, terms undisclosed: OpenAI is acquiring Orchestra Bio and merging it with its life sciences AI platform Rosalind to build AI agents for drug development. The agents will help pharma teams coordinate drug development, from tracking trials to spotting problems. Financial terms were not disclosed.

    Permalink

  • SpaceX • SpaceX

    SpaceX Q3 revenue rises 161% to $14.58B while AI revenue jumps 830% to $7.56B: SpaceX reported Q3 revenue of $14.58B, up 161% year over year and above the $12.72B estimate. AI revenue rose 830% to $7.56B, and AI operating income was $431M, up from a $1.7B loss.

    Permalink